Finance

Lists
GLAND:NSE
Gland Pharma Ltd
3 330,00 INR
+1,13%
(+37,10) 1D
20 ნოე, 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for GLAND...
Open
3 291,50 INR
High
3 339,10 INR
Low
3 279,70 INR
Mkt. cap
549,50 მლრ.
Avg. vol.
446,96 ათ.
Volume
300,57 ათ.
Dividend
0,60%
Quarterly dividend
5,00 INR
Ex-dividend date
11 აგვ. 2026
P/E ratio
44,48
52-wk high
3 429,00 INR
52-wk low
1 573,60 INR
EPS
74,86 INR
No. of employees
4 ათ.
Open
3 291,50 INR
High
3 339,10 INR
Low
3 279,70 INR
Mkt. cap
549,50 მლრ.
Avg. vol.
446,96 ათ.
Volume
300,57 ათ.
Dividend
0,60%
Quarterly dividend
5,00 INR
Ex-dividend date
11 აგვ. 2026
P/E ratio
44,48
52-wk high
3 429,00 INR
52-wk low
1 573,60 INR
EPS
74,86 INR
No. of employees
4 ათ.
News stories
From web sources and news partners
About Gland Pharma Ltd
CEOShyamakant Giri
Employees4,33 ათ.
Founded1978
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Last report
6 ნოე. 2026
Fiscal period
Q2 2027
17,62 INR / 17,14 INR
+2,82%beat
Revenue / Est. (INR)
18,34 მლრდ. / 17,66 მლრდ.
+3,80%beat
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
დეკ. 2025
მარ. 2026
ივნ. 2026
სექ. 2026
Revenue
16,95 მლრდ.
17,43 მლრდ.
18,00 მლრდ.
18,34 მლრდ.
Cost of goods sold
6,31 მლრდ.
8,32 მლრდ.
6,80 მლრდ.
7,30 მლრდ.
Cost of revenue
6,31 მლრდ.
8,32 მლრდ.
6,80 მლრდ.
7,30 მლრდ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4,24 მლრდ.
4,26 მლრდ.
4,44 მლრდ.
4,12 მლრდ.
Operating expense
7,37 მლრდ.
5,22 მლრდ.
7,42 მლრდ.
7,35 მლრდ.
Total operating expenses
13,68 მლრდ.
13,54 მლრდ.
14,22 მლრდ.
14,65 მლრდ.
Operating income
3,27 მლრდ.
3,89 მლრდ.
3,78 მლრდ.
3,69 მლრდ.
Other non operating income
631,73 მლნ.
-1,79 მლრდ.
612,28 მლნ.
690,48 მლნ.
EBT including unusual items
3,62 მლრდ.
5,06 მლრდ.
4,35 მლრდ.
4,31 მლრდ.
EBT excluding unusual items
3,86 მლრდ.
5,02 მლრდ.
4,35 მლრდ.
4,31 მლრდ.
Income tax expense
1,01 მლრდ.
1,39 მლრდ.
1,18 მლრდ.
1,40 მლრდ.
Effective tax rate
27,79%
27,51%
27,13%
32,53%
Other operating expenses
2,06 მლრდ.
-130,22 მლნ.
1,87 მლრდ.
2,08 მლრდ.
Net income
2,61 მლრდ.
3,67 მლრდ.
3,17 მლრდ.
2,91 მლრდ.
Net profit margin
15,42%
21,04%
17,61%
15,86%
Earnings per share
16,98
22,23
19,22
17,62
Interest and investment income
-
2,06 მლრდ.
-
-
Interest expense
-39,30 მლნ.
-63,09 მლნ.
-43,61 მლნ.
-71,38 მლნ.
Net interest expenses
-39,30 მლნ.
1,99 მლრდ.
-43,61 მლნ.
-71,38 მლნ.
Depreciation and amortization charges
1,08 მლრდ.
1,09 მლრდ.
1,11 მლრდ.
1,15 მლრდ.
EBITDA
4,17 მლრდ.
4,91 მლრდ.
4,80 მლრდ.
4,82 მლრდ.
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google აპები